The role of endothelium-derived contracting factor or factors in modulating relaxations and contractions to adenine nucleotldes was examined in aortas from spontaneously hypertensive rats (SHR) and nonnotensive Wistar-Kyoto (WKY) and Wlstar rats. During contractions to phenylephrine, the relaxations to ATP were impaired significantly in SHR compared with WKY aortas with endothelium. In rings treated with A fG -nltro-L-arginine (to inhibit nitric oxide synthase), the endothelium significantly augmented contractions evoked by ATP; this enhancement was greater in SHR compared with WKY aortas. Indomethacin (inhibitor of cyclooxygenase) and SQ 29,458 (antagonist of thromboxane/prostaglandin endoperoxide receptors) but not dazoxiben (inhibitor of thromboxane synthase) significantly augmented the maximal relaxation in WKY rats, abolished the impairment of the relaxation in SHR, and prevented the potentiation by the endothelium of the contractions evoked by ATP. In older animals (10 to 12 months old), the endothelium-dependent concentration-relaxation curves to ATP in SHR and WKY aortas treated with indomethacin were superimposable, as were the concentration-contraction curves (with <V G -nitro-Larginine present). Endothelium-dependent concentration-relaxation and -contraction curves to ADP obtained in these preparations overlapped also. In Wistar rats, the magnitude of the endotheliumdependent relaxations to either ATP or ADP were significantly smaller compared with the other strains, and the endothelium-dependent contractions were even smaller. Results show that adenine nucleotides stimulate the production of both endothelium-derived relaxing and contracting factors. Although there is no obvious age-related alteration in the capacity of aortas to release endothelium-derived relaxing factor, aging enhances endothelium-derived contracting factor activity in WKY rats. The former can be attributed to the release of endotheliumderived relaxing factor, which most likely is nitric oxide or a related nitrosocompound. 24 The contractions have been attributed to the release of endothelium-derived contracting factor, which most likely is a prostaglandin endoperoxide. 58 The two mediators released by acetylcholine interact 79 ; thus, prevention of the production of endothelium-derived contracting factor by inhibitors of cyclooxygenase potentiates endothelium-dependent relaxations. In contrast, inhibition of the production of endothelium-derived relaxing factor (nitric oxide) augments the contraction to the cholinergic transmitter.
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The role of endothelium-derived contracting factor or factors in modulating relaxations and contractions to adenine nucleotldes was examined in aortas from spontaneously hypertensive rats (SHR) and nonnotensive Wistar-Kyoto (WKY) and Wlstar rats. During contractions to phenylephrine, the relaxations to ATP were impaired significantly in SHR compared with WKY aortas with endothelium. In rings treated with A fG -nltro-L-arginine (to inhibit nitric oxide synthase), the endothelium significantly augmented contractions evoked by ATP; this enhancement was greater in SHR compared with WKY aortas. Indomethacin (inhibitor of cyclooxygenase) and SQ 29, 458 (antagonist of thromboxane/prostaglandin endoperoxide receptors) but not dazoxiben (inhibitor of thromboxane synthase) significantly augmented the maximal relaxation in WKY rats, abolished the impairment of the relaxation in SHR, and prevented the potentiation by the endothelium of the contractions evoked by ATP. In older animals (10 to 12 months old), the endothelium-dependent concentration-relaxation curves to ATP in SHR and WKY aortas treated with indomethacin were superimposable, as were the concentration-contraction curves (with <V G -nitro-Larginine present). Endothelium-dependent concentration-relaxation and -contraction curves to ADP obtained in these preparations overlapped also. In Wistar rats, the magnitude of the endotheliumdependent relaxations to either ATP or ADP were significantly smaller compared with the other strains, and the endothelium-dependent contractions were even smaller. Results show that adenine nucleotides stimulate the production of both endothelium-derived relaxing and contracting factors. Although there is no obvious age-related alteration in the capacity of aortas to release endothelium-derived relaxing factor, aging enhances endothelium-derived contracting factor activity in WKY rats. I n the aorta of the spontaneously hypertensive rat (SHR), acetylcholine evokes both endotheliumdependent relaxations and contractions. 1 The former can be attributed to the release of endotheliumderived relaxing factor, which most likely is nitric oxide or a related nitrosocompound. 24 The contractions have been attributed to the release of endothelium-derived contracting factor, which most likely is a prostaglandin endoperoxide. 58 The two mediators released by acetylcholine interact 79 ; thus, prevention of the production of endothelium-derived contracting factor by inhibitors of cyclooxygenase potentiates endothelium-dependent relaxations. In contrast, inhibition of the production of endothelium-derived relaxing factor (nitric oxide) augments the contraction to the cholinergic transmitter. 7 ' 9 The role of endothelium-derived contracting factor increases with age in aortas of both the SHR and WistarKyoto (WKY) rat.
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In the aorta of the nonnotensive WKY rat, aggregating platelets cause contractions, which are reduced greatly in the presence of the endothelium 11 ; in contrast, the contractions to aggregating platelets are comparable in SHR - 15 The role of endothelium-derived relaxing factor in the relaxations to ATP and ADP was first demonstrated in canine arteries 16 ; this observation has been extended to other arteries, 17 including the rat aorta, 18 in which they are prevented by inhibitors of nitric oxide synthase.
19
- 20 However, adenine nucleotides also evoke contractions of vascular smooth muscle that are endothelium independent.
-

18
- 21 The presence of the endothelium potentiates contractions to both serotonin 11 ' 22 and ATP 19 in aortas from SHR and WKY rats, respectively. Thus, these reports suggest that the reduced inhibition by the endothelium of the contractions to aggregating platelets observed in the SHR aorta 11 could be due either to a reduced release of endothelium-derived relaxing factor or to an increased production of endothelium-derived contracting factor in response to the platelet products. The present experiments were designed to compare in aortas from SHR and WKY rats the endothelium-dependent and -independent responses (relaxations and contractions) to adenine nucleotides.
Methods
The methods and procedures described in the present report were reviewed by the animal protocol review WKY indicates Wistar-Kyoto rats; SHR, spontaneously hypertensive rats; and ND, not determined. Data are mean±SEM.
•Statistically significant age-related differences within the same strain. tStatistically significant strain-related differences for rats of the same age. and cleaned of loose connective tissue. The aortas were cut into rings (4 to 5 mm); special care was taken not to damage the luminal surface of the preparations. In some rings, the endothelium was removed mechanically. 11 Rings with and without endothelium were suspended between two stirrups in organ chambers (20 tnL) filled with control solution (gassed with 95% 0^5 % CO 2 and maintained at 37°C). One of the stirrups was anchored to the inside of the organ chamber, and the other was connected to a force transducer (UC2, Gould Inc, Cleveland, Ohio) to record changes in isometric tension. In all experiments, the rings were stretched progressively to 2.5 g of tension, which corresponds to the optimal point of their length-active tension relation as determined by preliminary experiments (data not shown). After a 40-minute equilibration period, the control solution was replaced by a depolarizing solution containing 60 mmol/L KC1 (prepared by equimolar substitution of NaCl with KC1) to obtain a reference contraction. The removal of the endothelium was checked by demonstrating the absence of relaxation to acetylcholine (10~5 mol/L) during submaximal contractions to phenylephrine (10~7 mol/L). 23 In rings treated with indomethacin (10~5 mol/L, inhibitor of cyclooxygenase) and contracted with phenylephrine (3xl0~6 mol/L), the cumulative addition of either ATP, ADP, or a,/3-methylene ATP was used to assess their ability to stimulate the release of endothelium-derived relaxing factor. In parallel experiments, concentration-contraction curves to the adenine nucleotides were constructed in rings with and without endothelium incubated previously with Af G -nitro-L-arginine (10~4 mol/L). 24 In some preparations, A^G-nitro-L-arginine caused contractions that exceeded 10% of the response to 60 mmol/L KC1; the experiments were discontinued, and only aortas in which the nitric oxide synthase inhibitor evoked marginal contractions were used to study the response to ATP. In some experiments, for determination of the involvement of endothelium-derived contracting factor, the rings were incubated for 40 minutes with either indomethacin (10~5 mol/L), dazoxiben (10~* mol/L, inhibitor of thromboxane synthase), or SQ 29,458 (10* 6 mol/L, antagonist of thromboxane/prostaglandin endoperoxide receptors) before the addition of adenine nucleotides.
Drugs and Chemicals
The following drugs were used: acetylcholine hydrochloride, ADP sodium salt, ATP Tris salt, o,£-methylene ATP lithium salt, indomethacin, phenylephrine hydrochloride (all from Sigma Chemical Co, St Louis, Mo), dazoxiben (Pfizer, Groton, Conn), Af°-nitro-Larginine (Aldrich Chemical Co, Milwaukee, Wis), and
. Drugs were prepared in water except for indomethacin (dissolved by sonication in water and Na 2 CO 3 , which had no effect at the final bath concentration of 5 x 10" 6 mol/L) and SQ 29,458 (dissolved in dimethyl sulfoxide; final bath concentration, 0.1% vol/vol).
Statistical Analysis
In each experimental group, n refers to the number of animals from which aortas were taken. Results are shown as mean±SEM. Relaxations are expressed as percent decreases in tension from the plateau-contraction evoked by phenylephrine (3xlO~6 mol/L). The contractions evoked by the adenine nucleotides under basal conditions are expressed as the percentage of the maximal response to 60 mmol/L KC1 obtained at the beginning of the experiment before drug treatment. The potency of agonists was determined as the pD 2 , which is the negative logarithm of the concentration causing half the maximal response. The maximal contraction to ATP could not be determined under the experimental conditions used, so its potency was estimated in terms of the EC20, which is the negative logarithm of the concentration of ATP causing a contraction equal to 20% of that evoked by 60 mmol/L KC1 in the same tissue. Statistical comparisons were performed by means of an analysis of variance or Student's / tests for paired and unpaired observations. Differences were considered to be statistically significant at a value of P<.05.
Results
ATP: Relaxations
Five-month-old WKY rats and SHR In WKY aortas with endothelium, the cumulative addition of ATP (10~8 to 10" 3 mol/L) during contractions to phenylephrine (3xlO~6 mol/L) caused concentration-dependent relaxations that were maximal at 10" 4 mol/L (Fig 1) . In SHR Table 2 ). *Statisticahy significant difference in maximal relaxation compared with control aortas, ATP also evoked concentration-dependent relaxations; however, higher concentrations of the agonist caused a rebound contraction (Fig 1) . In both WKY and SHR aortas, the relaxations evoked by ATP were abolished by the removal of the endothelium and in the presence of N G -nitro-L-arginine (10~4 mol/L, data not shown). In WKY rings with endothelium incubated with either indomethacin (1(T 5 mol/L), SQ 29,458 (10" 6 mol/L), or dazoxiben (10~4 mol/L), the contractions to phenylephrine were reduced significantly (see Table 2 ). In these preparations, the maximal relaxation to ATP was increased significantly by both indomethacin or SQ 29,458 but not by dazoxiben (Fig 1) . In SHR aortas with endothelium, the inhibitors of the arachidonic acid cascade did not affect significantly the contractions evoked by phenylephrine (Table 2) ; both indomethacin and SQ 29,458 inhibited the rebound in tension induced by higher concentrations of ATP, which then caused further relaxation (Fig 1) . The concentration-relaxation curves to ATP obtained in the presence of dazoxiben were not significantly different from control (Fig 1) . Twelve-month-old SHR and WKY and Wistar rats. In aortas of 12-month-old rats, the contractions evoked by phenylephrine (3xlO~6 mol/L) did not differ significantly among the three strains. The concentrationrelaxation curves to ATP obtained under these conditions were superimposable for the lower concentrations of the agonist (Fig 2) . However, the maximal response to ATP was significantly greater in preparations from SHR and WKY rats than in those from Wistar rats (Fig  2) . The maximal responses and pD 2 values obtained in mature SHR and WKY rats did not differ significantly from those obtained in younger animals (Table 3 and Figs 1 and 2) .
ATP: Contractions
Five-month-old WKY rats and SHR. The contractions induced by 60 mmol/L KCI did not differ significantly among groups even after endothelium removal (see Table 2 ). In the presence of N G -nitro-L-arginine (10~4 mol/L), the cumulative addition of ATP elicited concentration-dependent contractions in rings with endothelium from both WKY rats and SHR (Fig 3) . The ECa, of ATP was greater in aortas from SHR than in those from WKY rats ( Table 3) . Removal of the endothelium induced a shift to the right of the concentrationcontraction curves to ATP in preparations from both strains; the interspecies difference between WKY rats and SHR was no longer significant. In WKY rings with endothelium treated with either indomethacin (10~5 mol/L) or SQ 29,458 (10" 6 mol/L), there was a significant shift to the right of the concentration-contraction curves to ATP, that in the presence of these inhibitors did not differ significantly from those curves obtained in rings without endothelium (Fig 3) . In SHR, indomethacin and SQ 29,458 shifted the concentration-contraction curves to ATP below those obtained in rings without endothelium (Fig 3) . In both strains, dazoxiben did not affect the contractions to ATP (data not shown, n=2).
Twelve-month-old SHR and WKY and Wistar rats. ATP was equipotent in aortas from SHR and WKY rats and significantly less potent in those from Wistar rats (Table 3) endothelium treated with ,/V G -nitro-L-arginine (Fig 4) . Removal of the endothelium resulted in a significant shift to the right of the concentration-contraction curves obtained in the three strains (Fig 4) . The concentrationcontraction curves obtained in the Wistar aortas without endothelium remained to the right of those obtained in WKY and SHR aortas and did not differ significantly (Fig 4) .
FIG 2. Plot shows concentration-relaxation curves to ATP in aortas with endothelium from mature Wistar rats (n=4, A), Wistar-Kyoto (WKY) normotensive rats (n=6, m), and spontaneously hypertensive rats (SHR) (n=5, • ) . Preparations were incubated with indomethacin (10~s mol/L) and contracted with phenylephrine (Phe) (3xl0~6 mol/L
ADP
Relaxations evoked by ADP were investigated in aortas incubated with indomethacin and contracted •Statistically significant age-related difference within the same strain. tStatisticaHy significant differences with responses of WKY rats in the same age group.
with phenylephrine (3x10 6 mol/L) from 12-month-old rats. ADP evoked concentration-dependent relaxations in preparations from SHR and WKY and Wistar rats (Fig 5) . The maximal relaxation induced by ADP was comparable in aortas from SHR (53.9±6.9%, n=5) and WKY rats (55.9±12.4%, n = 6) but was significantly smaller in Wistar rats (35.1+8.21%, n=4). The pD 2 values (SHR, 6±0.1; WKY, 6.1 ±0.2; Wistar, 5.8±0.2) did not differ significantly among strains. The maximal relaxation to ATP was significantly greater than that induced by ADP in all strains.
In preparations with endothelium treated with N anitro-L-arginine, ADP evoked concentration-dependent contractions (Fig 5) , the maximum of which was significantly greater in aortas from SHR (43.6±6.5%, n=5) and WKY rats (45.1±12.1%, n=6) than in preparations from Wistar rats (12.5±7.2%, n=4). Endothelium removal significantly inhibited the contractions in aortas from the three strains (Fig 5) .
a,p-Methylene ATP
In aortas with endothelium (incubated with 10" 5 mol/L indomethacin and contracted with 3xlO" 6 mol/L phenylephrine) taken from 12-month-old SHR, the cumulative addition of a,/3-methylene ATP (10~8 to 10" 4 mol/L; a stable analogue of ATP) did not cause relaxation but induced further increases in tension during contraction to phenylephrine (Fig 6) .
In preparations incubated with 10~4 mol/L iV G -nitro-Larginine, a,/3-methylene ATP induced concentration-dependent contractions that were larger in rings with than in those without endothelium (Fig 6) . In the presence of indomethacin, the contractions to a,/3-methylene ATP were significantly reduced in rings with endothelium; at 3xlO~5 mol/L, they averaged 20.0±2.7% of the response to 60 mmol/L KCI in the presence of indomethacin compared with 39.0±6.7% in control (n=3). The contractions obtained in the presence of the inhibitor of cyclooxygenase did not differ significantly from those obtained in rings without endothelium.
Discussion
The results indicate that the endothelium-dependent relaxations to ATP are impaired in aortas from SHR by the production of an endothelium-derived contracting factor. To further characterize this effect of ATP, experiments determined (1) whether the production of endothelium-derived contracting factor induced by ATP in the aorta of the WKY rat augments with age as shown previously for acetylcholine 810 ; experiments also (2) assessed whether or not this augmentation is accompanied by an increase in the sensitivity of endothelial cells to ATP, (3) assessed the relaxations and contractions to ADP, and (4) compared the responses to ATP in SHR and WKY rats with those in Wistar rats of the same age to further document strain-related differences. Finally, the question was addressed whether or not the endothelium modulates the contraction of vascular smooth muscle induced by a,/3-methylene ATP, which is known to be endothelium independent in most blood vessels, 141721 including the rat aorta. 18 The impairment of the relaxation to ATP in rat aorta was not reported in previous studies, 10 ' 19 possibly because these authors only considered lower concentrations of ATP, for which there is no significant rebound in tension Table 2 ), which did not differ significantly in the different groups. *Statistically significant differences with responses observed in control preparations; ^statistically significant strainrelated differences.
as shown in the present study. However, a previous study in the rat showed an impairment of the endotheliumdependent relaxations to ATP in carotid arteries from SHR and aged WKY rats, although the mechanism involved in the reductions was not determined. 25 The present study demonstrates that the impairment is prevented in the presence of inhibitors of cyclooxygenase 26 or of thromboxane A 2 /endoperoxide receptors 27 but not of thromboxane synthase. Therefore, the endotheliumderived contracting factor involved in this impairment is very likely to be an endoperoxide, as is the case for the reduction of endothelium-dependent relaxations to acetylcholine.
1 -610 Endothelium-derived contracting factor mediates the potentiation by the endothelium of the contractions evoked by ATP in aortas treated with the nitric oxide synthase inhibitor 7V G -nitro-L-arginine. Indeed, like the endothelium-dependent contractions to acetylchoUne, 69 the latter component of the contraction elicited by ATP is prevented in the presence of inhibitors of cyclooxygenase or of thromboxane A 2 /endoperoxide receptors but not of thromboxane synthase.
To judge from the increase in endothelium-dependent contractions, there is an enhanced production and/or action of endothelium-derived contracting factor with age. It has been suggested that this may be correlated with blood pressure elevation. 8 Although there was indeed a significant increase of blood pressure in WKY rats, it still remained below the levels obtained in 5-month-old SHR. Because the endothelium-dependent contractions in old WKY rats are greater than those obtained in 5-month-old SHR, the moderate elevation of blood pressure in WKY rats may not account fully for the obtained potentiation. The endothelium-dependent relaxations obtained in the presence of indomethacin were comparable in both strains and did not differ significantly from those observed in the younger animals under identical conditions. Therefore, the increase of endothelium-dependent contractions with age in WKY rats and hypertension in SHR is not a consequence of a nonspecific increase in the sensitivity of endothelial cells to ATP. Rather, because the induction of the production of endothelium-derived relaxing factor and prostanoids by adenine nucleotides is dependent on the mobilization of intracellular calcium, 28 the lack of significant age-related alteration of the endothelium-dependent relaxations suggests that this increase may reflect an enhanced metabolism of arachidonic acid. 29 The endothelium-dependent responses, contractions and relaxations, to ADP obtained in aortas of old WKY rats and SHR, respectively, were comparable. However, in terms of maximal response (relaxation or contrac- tion), ADP was less efficacious than ATP in both strains. This difference has been documented previously for endothelium-dependent relaxations caused by adenine nucleotides and may be attributed to nucleotide receptor heterogeneity in the rat aorta. 30 Thus, P^-purinoceptors present in endothelial cells mediate the relaxation to ADP, whereas in addition, relaxations to ATP involve the so-called nucleotide receptors, which are activated poorly by ADP. 30 The present results show that ADP evokes the production of endothelium-derived contracting factor, which then explains the impairment of the relaxations to this purine in the SHR aorta reported previously. 11 In aortas from aged Wistar rats, the endotheliumdependent contractions obtained with both ATP and ADP were significantly less than in preparations from aged SHR and WKY rats. Similarly, the direct stimulation of vascular smooth muscle in rings without endothelium and the endothelium-dependent relaxations were also smaller in comparison with the same effects in aortas from SHR and WKY rats. Whether this reduced responsiveness results from in vivo desensitization, by virtue of a greater endogenous stimulation, or stems from genetic differences in receptor density and/or coupling cannot be inferred from the data collected in this study.
To judge from the results obtained in aortas from SHR treated with indomethacin, a,£-methylene ATP 21 does not evoke endothelium-dependent relaxation as reported previously in aortas from normotensive rats. 18 These findings suggest that P^-purinoceptors, if present in endothelial cells, may not be coupled to the mechanisms that elevate cytosolic calcium and trigger the production of both endothelium-derived relaxing factor and prostaglandins, contrary to P^-purinoceptors 1728 and the so-called nucleotide receptors. 30 Nevertheless, the presence of the endothelium potentiated slightly but significantly the contractions to a,/3-methylene ATP, an effect mediated by an endothelium-derived contracting factor because it was abolished by indomethacin. Taking into consideration the lack of evidence as yet for endothelial P^-purinoceptors, this potentiation may reflect a subthreshold, spontaneous release of an endothelium-derived contracting factor. In conclusion, the present study demonstrates that ATP and ADP evoke the production of endotheliumderived contracting factor and endothelium-derived relaxing factor in SHR and old WKY aortas. The adenine nucleotides, when released from platelets, endothelial cells, or both, 31 -32 could participate in the regulation of the production of endothelium-derived contracting factor in vivo. The enhanced production of endotheliumderived contracting factor in SHR and old WKY rats may counteract the modulatory function of endothelium-derived relaxing factor and impair the vasodilator action of adenine nucleotides. 11 
